Søgning på udtrykket 'monkeypox' giver 41 resultater
Kalender [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Kalender [1]
15. november 2022, København og online
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Clinical Infectious Diseases
17.04.2024
Abstract . Retrospective surveillance leveraging male rectal swab sample remnants from I Want The Kit from July 2021 through October 2023, identified one symptomatic and one asymptomatic mpox case at the peak of transmission in 2022. Although sporadic cases continue to be reported in Maryland, additional asymptomatic cases were not identified in this leveraged surveillance.
BMC Infectious Diseases
16.04.2024
. Abstract. . Background. Monkeypox is an emerging infectious disease with confirmed cases and deaths in several parts of the world. In light of this crisis, this study aims to analyze the global knowledge pattern of monkeypox-related patents and explore current trends and future technical directions in the medical development of monkeypox to inform research and policy. . . . …
Emerg Microbes Infect
15.04.2024
Volume 13, Issue 1, December 2024 .
Emerg Microbes Infect
1.04.2024
Volume 13, Issue 1, December 2024 .
International Journal of Infectious Diseases
21.03.2024
Human monkeypox, a previously rare viral zoonosis, predominantly endemic to central and western Africa, emerged in May 2022 in non-endemic countries [1]. Initially confirmed in England [2], human autochthonous cases spread across 113 countries around the world, including 106 countries which had never previously reported monkeypox virus (MPXV) (www.cdc.gov/poxvirus/mpox/response/2022/world-map.html). Nearly 26,000 cases have been reported in Europe (https://monkeypoxreport.ecdc.europa.eu/).
BMC Infectious Diseases
8.03.2024
. Abstract. . Background and objective. Monkeypox virus (MPXV) is the causative agent of monkeypox’s zoonotic infection and was declared a global emergency by the World Health Organization (WHO). Studies from different countries have shown insufficient knowledge among the general public on MPXV. This study aimed to assess the knowledge of the general public of Nepal on MPXV. . . . …
Journal of Medical Virology
8.03.2024
Journal of Medical Virology, Volume 96, Issue 3, March 2024.
BMC Infectious Diseases
7.03.2024
. Abstract. . Background and objective. Monkeypox virus (MPXV) is the causative agent of monkeypox’s zoonotic infection and was declared a global emergency by the World Health Organization (WHO). Studies from different countries have shown insufficient knowledge among the general public on MPXV. This study aimed to assess the knowledge of the general public of Nepal on MPXV. . . . …
Proceedings of the National Academy of Sciences
21.02.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 8, February 2024.
Journal of Medical Virology
1.02.2024
Journal of Medical Virology, Volume 96, Issue 2, February 2024.
Journal of Medical Virology
1.02.2024
Journal of Medical Virology, Volume 96, Issue 2, February 2024.
Emerg Microbes Infect
31.01.2024
Volume 13, Issue 1, December 2024 .
Journal of Medical Virology
20.01.2024
Journal of Medical Virology, Volume 96, Issue 1, January 2024.
Journal of Infectious Diseases
19.01.2024
Abstract . Background . Pathology and monkeypox virus (MPXV) tissue tropism in severe and fatal human mpox is not thoroughly described but can help elucidate the disease pathogenesis and the role of coinfections in immunocompromised patients.Methods . We analyzed biopsy and autopsy tissues from 22 patients with severe or fatal outcomes to characterize pathology and viral antigen and DNA distribution in tissues by immunohistochemistry and in situ hybridization. Tissue-based testing for coinfections was also …
BMC Infectious Diseases
18.01.2024
…painful skin lesions and genital ulcers; polymerase chain reaction (PCR) from the lesions was positive for mpox. Twelve days later he was admitted with fever and confusion. Neuroimaging and CSF analysis indicated encephalitis. The CSF was PCR-negative for monkeypox virus but intrathecal antibody production was detected. He spontaneously improved over a few days course and recovered fully. . . . Conclusions. This case of mpo…
Journal of Medical Virology
5.01.2024
Journal of Medical Virology, Volume 96, Issue 1, January 2024.
Journal of Infectious Diseases
4.01.2024
Abstract . Monkeypox virus (MPXV) is a re-emerging virus of global concern. An outbreak of Clade I MPXV affected 20 captive chimpanzees in Cameroon in 2016. We describe the epidemiology, virology, phylogenetics, and clinical progression of this outbreak. Clinical signs included exanthema, facial swelling, peri-laryngeal swelling, and eschar. Mpox can be lethal in captive chimpanzees with death likely resulting from respiratory complications. We advise avoiding anesthesia in animals with respiratory signs to…
Emerg Microbes Infect
30.12.2023
Volume 12, Issue 1, December 2023 .
Emerg Microbes Infect
30.12.2023
Volume 12, Issue 1, December 2023 .
Journal of Medical Virology
7.12.2023
Journal of Medical Virology, Volume 95, Issue 12, December 2023.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Eurosurveillance latest updates
19.04.2024
. Background. Mpox, caused by monkeypox virus (MPXV), was considered a rare zoonotic disease before May 2022, when a global epidemic of cases in non-endemic countries led to the declaration of a Public Health Emergency of International Concern. Cases of mpox in Ireland, a country without previous mpox reports, could reflect extended local transmission or multiple epidemiological introductions. . . Aim. To elucidate the origins and molecular characteristics of MPXV circulating in Ireland between May 2022 …
ECDC Epidemiological Update
5.04.2024
Since December 2023 there has been a large increase in the number of mpox cases reported in the Democratic Republic of the Congo (DRC).
Eurosurveillance latest updates
15.03.2024
Since the beginning of 2023, the number of people with suspected monkeypox virus (MPXV) infection have sharply increased in the Democratic Republic of the Congo (DRC). We report near-to-complete MPXV genome sequences derived from six cases from the South Kivu province. Phylogenetic analyses reveal that the MPXV affecting the cases belongs to a novel Clade I sub-lineage. The outbreak strain genome lacks the target sequence of the probe and primers of a commonly used Clade I-specific real-time PCR. .
ECDC Epidemiological Update
14.01.2023
Since the start of the outbreak: A total of 1 158 cases have been confirmed in the EU/EEA and 1 882 cases have been confirmed worldwide (including the EU/EEA).
Eurosurveillance latest updates
15.12.2022
Modified vaccinia virus Ankara vaccine (MVA-BN; Bavarian Nordic) is recommended to contacts of mpox cases up to 14 days post-exposure but the effectiveness of this strategy is unknown. Among 108 adults (≥ 18 years old) who received one dose of MVA-BN after exposure to mpox, 11 (10%) cases of breakthrough mpox were observed. Sexual exposure was associated with the risk of breakthrough mpox (p = 0.0179). Samples taken from vaccinated breakthrough mpox cases had similar rate…
ECDC Epidemiological Update
8.12.2022
This report provides an overview of the total number of cases of mpox (monkeypox) reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .
Medscape Infectious Diseases
2.12.2022
A new model has been developed to guide public health policy makers on the most efficient way to distribute a limited supply of monkeypox vaccines to those who need it the most. . Medscape Medical News
Eurosurveillance latest updates
1.12.2022
Over 79,000 confirmed cases of mpox were notified worldwide between May and November 2022, most of them in men who have sex with men. Cases in women, for whom mpox might pose different risks, are rare, and Spain has reported more than one third of those in Europe. Using surveillance data, our study found similar time trends, but differences in delay of diagnosis, sexual transmission and signs and symptoms between men and women.
Eurosurveillance latest updates
1.12.2022
HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.
Eurosurveillance latest updates
1.12.2022
Vaccination is important in containing the 2022 mpox (formerly monkeypox) epidemic. We describe five Belgian patients with localised severe symptoms of proctitis and penile oedema, occurring between 4 and 35 days after post-exposure preventive vaccination or after one- or two-dose off-label pre-exposure preventive vaccination with MVA-BN vaccine. Genome sequencing did not reveal evidence for immune escape variants. Healthcare workers and those at risk should be aware of possible infections occurring shortly…
ProMED
30.11.2022
Monkeypox -- Andorra / 4Argentina / 894Aruba / 3Australia / 143Austria / 326Bahamas / 2Bahrain / 1Barbados / 1Belgium / 789 (1 fatal)Benin / 3Bermuda / 1Bolivia / 252Bosnia and Herzegovina / 9Brazil / 9905 (12 fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1449Central African Republic / 12Chile / 1278 (1 fatal)China / 1Colombia / 3803Costa Rica / 24Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 70 (1 fatal)Dem Republic Congo /
ProMED
25.11.2022
Monkeypox -- NetherlandsAbstract--------In 2009, the WHO proposed Guidelines on Hand Hygiene in Health Care, a document to implement use of 2 alcohol-based hand rubs (formulation I and II) for surgical and hygiene hand disinfection in healthcare settings and to reduce transmission of pathogens. However, inactivation efficacies of these products against MPVX [monkeypox virus] have not been determined. We evaluated the WHO-recommended alcohol-based formulations against MPXV and performed a comparative inactiv…
ProMED
23.11.2022
Monkeypox -- Confirmed cases by country as of 21 Nov 2022:Country / CasesAndorra / 4Argentina / 865Aruba / 3Australia / 141Austria / 326Bahamas / 2Bahrain / 1Barbados / 1Belgium / 786 (1 fatal)Benin / 3Bermuda / 1Bolivia / 251Bosnia and Herzegovina / 9Brazil / 9788 (12 fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1449Central African Republic / 12Chile / 1259 (1 fatal)China / 1Colombia / 3719Costa Rica / 23Croatia / 29Cuba / 8 (1 fatal)Curacao /
ProMED
20.11.2022
Monkeypox -- Andorra / 4Argentina / 862Aruba / 3Australia / 141Austria / 325Bahamas / 2Bahrain / 1Barbados / 1Belgium / 786 (1 fatal)Benin / 3Bermuda / 1Bolivia / 251Bosnia and Herzegovina / 9Brazil / 9675 (12 fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1445Central African Republic / 12Chile / 1260 (1 fatal)China / 1Colombia / 3719Costa Rica / 23Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 70 (1 fatal)Dem Republic Congo /
ProMED
17.11.2022
Monkeypox -- United StatesAlabama / 171Alaska / 5Arizona / 538Arkansas / 70California / 5547Colorado / 369Connecticut / 143Delaware / 41District of Columbia / 522Florida / 2784*Georgia / 1942Hawaii / 35Idaho / 15Illinois / 1404Indiana / 264Iowa / 27Kansas / 36Kentucky / 74Louisiana / 290Maine / 12Maryland / 726Massachusetts / 445Michigan / 372Minnesota / 233Mississippi / 106Missouri / 174Montana / 7Nebraska / 31Nevada / 304New Hampshire / 33New Jersey /
ProMED
16.11.2022
Monkeypox -- In this update:[1] Cases around the world******[1] Cases around the worldCountry / CasesAndorra / 4Argentina / 808Aruba / 3Australia / 141Austria / 325Bahamas / 2Bahrain / 1Barbados / 1Belgium / 785 (1 fatal)Benin / 3Bermuda / 1Bolivia / 248Bosnia and Herzegovina / 9Brazil / 9637 (12 fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1444Central African Republic / 12Chile / 1243China / 1Colombia / 3630Costa Rica / 16Croatia / 29Cuba /
ProMED
12.11.2022
Monkeypox -- Key figures-----------Confirmed cases: 79 151Deaths: 49Countries reporting cases: 1101. OverviewThis report provides a global overview of the monkeypox epidemiological situation as reported to WHO as of 10 Nov 2022. The report focuses on laboratory confirmed cases (for the WHO European region, both confirmed and probable cases are included within confirmed case counts and detailed case data) as defined by the WHO's working case definition published in the Surveillance, case
ProMED
11.11.2022
Monkeypox -- Andorra / 4Argentina / 746Aruba / 3Australia / 141Austria / 325Bahamas / 2Bahrain / 1Barbados / 1Belgium / 785 (1 fatal)Benin / 3Bermuda / 1Bolivia / 245Bosnia and Herzegovina / 9Brazil / 9541 (11 fatal)Bulgaria / 6Cameroon / 16 (2 fatal)Canada / 1444Central African Republic / 12Chile / 1208China / 1Colombia / 3630Costa Rica / 15Croatia / 29Cuba / 8 (1 fatal)Curacao / 3Cyprus / 5Czechia / 70 (1 fatal)Dem Republic Congo / 206Denmark /
Medscape Infectious Diseases
10.11.2022
And kids don't appear to be passing it to each other in school or daycare. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
10.11.2022
This report describes epidemiologic features of the United States Monkeypox outbreak and CDC's emergency responses.